Status:

COMPLETED

Impact of COVID-19 Vaccination on Balance Function Among Adolescents: A Long-Term Perspective

Lead Sponsor:

Sinai University

Conditions:

SARS CoV 2 Vaccination

Eligibility:

All Genders

10-17 years

Brief Summary

Long term impact of COVID 19 vaccination on dizziness-related disability and balance in adolescence

Eligibility Criteria

Inclusion

  • Adolescence age range 10-17
  • received a dose or more of an approved COVID-19 vaccine at least one year before the study enrollment.
  • the ability to complete all assessment measures independently.

Exclusion

  • vestibular or neurological disorders diagnosed before vaccination.
  • mixed COVID-19 vaccine types.
  • a history of traumatic brain injury.
  • current use of medications that affect balance.
  • documented COVID-19 infection within three months of assessment.
  • physical limitations that prevented them from completing balance testing.

Key Trial Info

Start Date :

December 6 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2024

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT06503926

Start Date

December 6 2023

End Date

July 1 2024

Last Update

July 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sinai University

Ismailia, Ismailia Governorate, Egypt, 11749